% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

  • nicehedges nicehedges Apr 7, 2014 9:47 AM Flag

    PIP:BARDA decides to de-scope SparVax

    ANNAPOLIS, Md., April 7, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that it has received notice from the Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA), advising the Company of its decision to de-scope the current SparVax® anthrax vaccine contract through a partial termination for convenience. BARDA will provide additional guidance to PharmAthene on the contractual changes, following which PharmAthene will evaluate its options with respect to its SparVax® program.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.460.00(0.00%)Mar 13 4:00 PMEDT